Top Markets
#1 DogBull DogBull +108.63%
#2 Siacoin Siacoin +66.67%
#3 MarsCoin MarsCoin +60.42%
#4 ADO Protocol ADO Protocol +53.58%
#5 The Bitcoin Bull The Bitcoin Bull +31.93%
#6 Ontology Gas Ontology Gas +22.49%
#7 Akedo Akedo +12.84%
#8 UnifAI Network UnifAI Network +11.47%
#9 AI XOVIA AI XOVIA +11.39%
#10 Cryptopia Cryptopia +10.51%
Coin of the day
DogBull DogBull
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Zhejiang Taimei Medical Technology Co., Ltd. Zhejiang Taimei Medical Technology Co., Ltd.

Zhejiang Taimei Medical Technology Co., Ltd.

2576
Classificação em ações #15029
Zhejiang Taimei Medical Technology Co., Ltd., established in 2013 and based in... Zhejiang Taimei Medical Technology Co., Ltd., established in 2013 and based in Jiaxing, China, specializes in delivering sophisticated digital operational platforms specifically designed for the biopharmaceutical industry across the country. The company's core offering is TrialOS, a comprehensive digital collaboration platform that seamlessly integrates all participants throughout the drug development and research lifecycle. This ecosystem effectively links hospitals, pharmaceutical firms, external service providers, regulatory bodies, and patients, among other key industry stakeholders. Its extensive portfolio of software solutions caters to various critical aspects of clinical research and drug development. For streamlining clinical trial operations, Taimei Medical provides tools like eCooperate, which optimizes management systems and leverages big data for informed decision-making. Other related offerings include eArchives for managing master files, eCollect for electronic data capture, eCollege for training administration, eQuality for electronic audit processes, and eBalance for interactive web-based responses. Innovations such as eVisit Patient Reported Outcomes are designed to enhance patient data input and accuracy, while eTime supports project time management, and eImage facilitates medical image interpretation. Furthermore, the company supplies specialized software tailored for hospitals and Good Clinical Practice (GCP) sites. These include eTrial for managing Phase I wards, eSite and NomenCTMS for comprehensive clinical trial management at study sites, and intelligent platforms like GCP-X and Intelligent Investigator. Solutions such as eScreening assist with subject information management and deduplication, while IIT-EDC and the Investigator-Initiated Clinical Trial Management System support investigator-initiated studies and their associated data management. In the crucial domain of drug safety, the company offers robust pharmacovigilance software solutions. This includes both global and intelligent eSafety systems, alongside the SAE Manager for efficient communication and management of critical safety data during clinical trials. Complementing these, Zhejiang Taimei also develops marketing software and a variety of other digital innovation solutions.
Preço da ação
$0.67033345
Valor de mercado
$377.97M
Variação (1 dia)
-3.68%
Variação (1 ano)
5.38%
País
CN
Negociar Zhejiang Taimei Medical Technology Co., Ltd. (2576)

Categoria

Technology
Rácio P/E de Zhejiang Taimei Medical Technology Co., Ltd. (2576)
Rácio P/E em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da Zhejiang Taimei Medical Technology Co., Ltd., o rácio P/E atual (TTM) é 0. No final de 2026, a empresa tinha um P/E de 0.
Histórico do rácio P/E da Zhejiang Taimei Medical Technology Co., Ltd. de 2026 a 2026
Rácio P/E no final de cada ano
Ano Índice P/E Alterar
Não há dados suficientes para as datas fornecidas.
Rácio P/E para empresas semelhantes ou concorrentes
Empresa Rácio P/E Diferença do rácio P/E País
SAP SE SAP SE
SAP SE
SAP.DE
 27.13 -
DE
Salesforce, Inc. Salesforce, Inc.
Salesforce, Inc.
CRM.US
 23.41 -
US
Shopify Inc. Shopify Inc.
Shopify Inc.
SHOP.TO
 - -
CA
Uber Technologies, Inc. Uber Technologies, Inc.
Uber Technologies, Inc.
UBER.US
 16.34 -
US
ServiceNow, Inc. ServiceNow, Inc.
ServiceNow, Inc.
NOW.US
 91.92 -
US
Como interpretar um P/E Ratio?

O rácio Preço/Lucro (P/E) mede a relação entre o preço da ação de uma empresa e o lucro por ação.
Um P/E baixo mas positivo representa uma empresa com altos lucros face à sua valorização atual e pode estar subvalorizada. Um P/E negativo elevado (perto de 0) representa perdas significativas.

Empresas com P/E acima de 30 ou negativo são geralmente vistas como "ações de crescimento", significando que os investidores esperam crescimento ou rentabilidade futura.

Empresas com P/E positivo inferior a 10 são geralmente consideradas "ações de valor", ou seja, já são muito lucrativas mas com pouco potencial de crescimento.